Aligned Genetics Inc (238120) — Cash Flow Reinvestment Rate
Aligned Genetics Inc (238120) has a Cash Flow Reinvestment Rate of 0.39x as of June 2025, reinvesting ₩265.20 Million (capex ₩165.20 Million plus investments ₩100.00 Million) from operating cash flow of ₩677.20 Million. Check 238120 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aligned Genetics Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Aligned Genetics Inc across 6 annual periods. Explore 238120 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Aligned Genetics Inc (2019–2024)
Year-by-year capital reinvestment analysis for Aligned Genetics Inc. For live market cap and broader valuation context, see 238120 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.57x | ₩7.89 Billion | ₩3.07 Billion | ₩340.06 Million | ▲ +237.6% |
| 2023 | 0.76x | ₩2.17 Billion | ₩2.85 Billion | ₩880.42 Million | ▼ -71.8% |
| 2022 | 2.70x | ₩6.00 Billion | ₩2.22 Billion | ₩2.00 Billion | ▼ -89.7% |
| 2021 | 26.15x | ₩3.56 Billion | ₩135.97 Million | ₩3.31 Billion | ▲ +17.1% |
| 2020 | 22.33x | ₩796.38 Million | ₩35.67 Million | ₩96.43 Million | ▲ +655.8% |
| 2019 | 2.95x | ₩1.95 Billion | ₩659.29 Million | ₩261.62 Million | — |